Edgewise Therapeutics, Inc. (EWTX) Social Stream



Edgewise Therapeutics, Inc. (EWTX): $9.83

-0.56 (-5.39%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add EWTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 404

in industry

Edgewise Therapeutics Inc (EWTX) Price Targets From Analysts

Use the tables below to see what analysts covering Edgewise Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-06 3 $34 $30 $31.666 $9.87 220.83%
2022-01-06 3 $34 $31 $32.666 $9.87 230.96%
2022-02-25 3 $34 $31 $32.333 $9.87 227.59%

The Trend in the Analyst Price Target


EWTX's average price target has moved down $2 over the prior 44 weeks.

EWTX reports an average of 70% for its upside potential over the past 44 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-08 NA 38 31 34.33 29.24 17.41%
2021-06-26 NA 35 29 32.67 23.95 36.41%
2021-07-10 NA 35 29 32.67 23.53 38.84%
2021-08-01 NA 35 29 32.67 17.51 86.58%
2021-08-14 NA 35 27 31.75 16.26 95.26%

EWTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


EWTX's average broker recommendation rating improved by 0.33 over the prior 123 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EWTX as an investment opportunity.

  • EWTX has a higher upside potential (average analyst target price relative to current price) than 270.12% of all US stocks.
  • In terms of how Edgewise Therapeutics Inc fares relative to all US stocks, note that its number of analysts covering the stock is greater than 33.42% of that group.
  • In terms of how Edgewise Therapeutics Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than 66.16% of that group.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Edgewise Therapeutics Inc's average analyst price target is greater than 215.62% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Edgewise Therapeutics Inc are EVLO, ETNB, and EPIX.

Is EWTX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.499 seconds.